Human dehydrogenase/reductase SDR family member 11 (DHRS11) and aldo-keto reductase 1C isoforms in comparison: Substrate and reaction specificity in the reduction of 11-keto-C19-steroids

J Steroid Biochem Mol Biol. 2020 May:199:105586. doi: 10.1016/j.jsbmb.2020.105586. Epub 2020 Jan 8.

Abstract

Recent studies have shown that an adrenal steroid 11β-hydroxy-4-androstene-3,17-dione serves as the precursor to androgens, 11-ketotestosterone and 11-ketodihydrotestosterone (11KDHT). The biosynthetic pathways include the reduction of 3- and 17-keto groups of the androgen precursors 11-keto-C19-steroids, which has been reported to be mediated by three human enzymes; aldo-keto reductase (AKR)1C2, AKR1C3 and 17β-hydroxysteroid dehydrogenase (HSD) type-3. To explore the contribution of the enzymes in the reductive metabolism, we kinetically compared the substrate specificity for 11-keto-C19-steroids among purified recombinant preparations of four AKRs (1C1, 1C2,1C3 and 1C4) and DHRS11, which shows 17β-HSD activity. Although AKR1C1 did not reduce the 11-keto-C19-steroids, AKR1C3 and DHRS11 reduced 17-keto groups of 11-keto-4-androstene-3,17-dione, 11-keto-5α-androstane-3,17-dione (11K-Adione) and 11-ketoandrosterone with Km values of 5-28 μM. The 3-keto groups of 11KDHT and 11K-Adione were reduced by AKR1C4 (Km 1 μM) more efficiently than by AKR1C2 (Km 5 and 8 μM, respectively). GC/MS analysis of the products showed that DHRS11 acts as 17β-HSD, and that AKR1C2 and AKR1C4 are predominantly 3α-HSDs, but formed a minor 3β-metabolite from 11KDHT. Since DHRS11 was thus newly identified as 11-keto-C19-steroid reductase, we also investigated its substrate-binding mode by molecular docking and site-directed mutagenesis of Thr163 and Val200, and found the following structural features: 1). There is a space that accommodates the 11-keto group of the 11-keto-C19-steroids in the substrate-binding site. 2) Val200 is a critical determinant for exhibiting the strict 17β-HSD activity of the enzyme, because the Val200Leu mutation resulted in both significant impairment of the 17β-HSD activity and emergence of 3β-HSD activity towards 5α-androstanes including 11KDHT.

Keywords: 11-Oxygenated androgen; Aldo-keto reductase; DHRS11; GC/MS; Hydroxysteroid dehydrogenase; Specificity determinant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 17-Hydroxysteroid Dehydrogenases / chemistry*
  • 17-Hydroxysteroid Dehydrogenases / genetics
  • 17-Hydroxysteroid Dehydrogenases / metabolism
  • 20-Hydroxysteroid Dehydrogenases / chemistry*
  • 20-Hydroxysteroid Dehydrogenases / genetics
  • 20-Hydroxysteroid Dehydrogenases / metabolism
  • Aldo-Keto Reductase Family 1 Member C3 / chemistry
  • Aldo-Keto Reductase Family 1 Member C3 / genetics
  • Aldo-Keto Reductase Family 1 Member C3 / metabolism
  • Aldo-Keto Reductases / chemistry*
  • Aldo-Keto Reductases / genetics
  • Aldo-Keto Reductases / metabolism
  • Androgens / biosynthesis
  • Androgens / chemistry
  • Biosynthetic Pathways / genetics
  • Humans
  • Molecular Docking Simulation
  • Oxidoreductases / chemistry
  • Oxidoreductases / genetics
  • Oxidoreductases / metabolism
  • Protein Isoforms / chemistry
  • Protein Isoforms / genetics
  • Steroids / biosynthesis*
  • Steroids / chemistry
  • Substrate Specificity
  • Testosterone / analogs & derivatives
  • Testosterone / metabolism

Substances

  • 11-ketodihydrotestosterone
  • Androgens
  • Protein Isoforms
  • Steroids
  • Testosterone
  • Oxidoreductases
  • 17-Hydroxysteroid Dehydrogenases
  • 17beta-hydroxysteroid dehydrogenase type 3
  • DHRS11 protein, human
  • 20-Hydroxysteroid Dehydrogenases
  • 3 alpha-beta, 20 beta-hydroxysteroid dehydrogenase
  • Aldo-Keto Reductases
  • AKR1C3 protein, human
  • Aldo-Keto Reductase Family 1 Member C3
  • trans-1,2-dihydrobenzene-1,2-diol dehydrogenase
  • 11-ketotestosterone